All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial…
December 05, 2025 20:00 ET | Source: ORIC Pharmaceuticals Highly differentiated 1L preliminary systemic activity of 67% ORR and 100%…
SOLAPUR, India, Dec. 3, 2025 /PRNewswire/ -- Fenova uPVC Door & Window Systems, a division of Arihant Profile – Extrusion…
Austin, TX, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Crypto Mondays Austin announces Regenerative Wealth, an innovative gathering that merges technology,…
BEIJING, Nov. 14, 2025 /PRNewswire/ -- Token Cat Limited (Nasdaq: TC) today announced that, after divesting its long-term unprofitable business and…
BEIJING, Oct. 31, 2025 /PRNewswire/ -- Amid the wave of the digital economy, new-generation digital technologies such as cloud computing,…
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…
Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared…
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data…
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical…